University of Louisville, U.S.
Results of recent studies reported by University of Louisville, U.S.
Published in Medical Patent Business Week, June 22nd, 2007
This trend article about University of Louisville, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Researchers detail in "Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line," new data in glaucoma. "Glaucoma is a progressive eye disease that leads to blindness due to loss of retinal ganglion cells (RGCs). There are difficulties in using primary cultures of purified RGC to study this pathophysiology," researchers in the United States report.
"RGC-5, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
More Articles from Medical Patent Business Week
- Alcoholism
European Patent Office Grants Hythiam Patent for Treatment of Alcohol Dependence - Barr Pharmaceuticals, Inc.
Barr Confirms Decision in Azithromycin Inventorship Suit - Biotechnology
BIO White Paper Dispels Over-Patenting Myth - Cancer
PhytoMedical To Develop New Class of Antitumour Agents Designed To Bind To DNA and Kill Cancer Cells - Diabetes
Recommended Changes to Enhance Minority Involvement in Clinical Research - Diagnostic Test
Corgenix AspirinWorks Test Kit Cleared by FDA - More from this issue of Medical Patent Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
